心臓病と脳卒中の統計:2023年更新:アメリカ心臓協会からの報告
Circulation
|January 25, 2023
まとめ
アメリカ 心臓協会
科学分野:
- 心血管保健 統計
- 公衆衛生の監視
- 心臓病 と 脳卒中 の 疫学
背景:
- アメリカ心臓協会と国立衛生研究所による 心血管健康統計の年次報告
- 心臓病,脳卒中,危険因子,行動 (喫煙,ダイエット,運動),健康指標 (コレステロール,血圧,グルコース) をカバーしています.
- 冠動脈疾患,心不全,外周動脈疾患などの様々な臨床状態のデータと結果とコストが含まれています.
研究 の 目的:
- 米国における心臓病と脳卒中に関する 最新の統計を提示します
- 心血管の健康,危険因子,および関連する状態の包括的な概要を提供する.
- 構造的な人種差別が健康格差に与える影響を強調し,健康の平等を促進する.
主な方法:
- アメリカ心臓協会の流行病学および予防統計委員会によるデータソースの継続的な監視と評価.
- 出版前の1年までの出版物のレビュー
- COVID-19 (新型コロナウイルス感染症 2019) の最新データと心血管健康モニタリングを含む.
主要な成果:
- 統計的な更新は,幅広い心血管疾患とその結果に関する詳細な統計を提供します.
- 各章は心臓病と脳卒中の統計に関する特定のトピックに焦点を当てています.
- 今年の最新版には 保健の公平性や 人口における心臓血管の健康上の利点に 焦点を当てています
結論:
- 統計の最新版は,公衆,政策立案者,医療従事者など,様々な聴衆にとって不可欠なリソースです.
- 心血管の健康に関する 最も信頼できるデータです
- この報告書は,心血管疾患の理解と対処,そしてよりよい公衆衛生成果の促進に役立ちます.
関連する概念動画
Atherosclerosis IV: Nursing Management
35
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
35
Atherosclerosis III: Management
16
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
16
Coronary Artery Disease IV: Preventive Measures
30
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
30
Ischemic Heart Disease: Overview
1.4K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Heart Failure I: Introduction
31
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
31
Peripheral Artery Disease III: Interprofessional Care
18
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
18


